Educational Events

South Florida Parkinson's Symposium

Virtual ( Zoom )
11:00 am to 2:00 pm EST
FREE
South Florida

Join us to discuss Parkinson's symptoms, treatments, and progression while we explore important factors in helping live your best life, including diet, exercise, and staying connected. This program will also feature a live Q & A with Parkinson's experts.

Expert Speakers

Ihtsham ul Haq, MD, FAAN
Professor of Neurology and Chief of Movement Disorders Divisions
University of Miami, Miller School of Medicine. 

Kimberly Amigo, DNP, APRN, AGACNP-BC
Memorial Neuroscience Institute

Annelly Bure-Reyes, PhD
Assistant Professor, Division of Neuropsychology and Cognitive Neuroscience
Department of Neurology, University of Miami Miller School of Medicine. 

Marina Sarno, PsyD
Assistant Professor, Division of Neuropsychology and Cognitive Neuroscience
Lead Neuropsychologist, Movement Disorders Division, Department of Neurology
University of Miami Miller School of Medicine. 

Melissa Grassia Chisholm, MS, CCC-SLP
CEO | Voice Rehab LLC

Valeria Garcia-Mallon, MS OTR/L
Memorial Hospital West Outpatient Rehabilitation

Rania Massad PT, DPT
Assistant Professor & Neurologic Residency Coordinator
Nova Southeastern University- Physical Therapy Program.

Sydney Hughes, CAP
Founder & CEO, Senior Proof

Moderator

Adolfo Diaz
Associate Vice President, Information & Resources
Parkinson's Foundation

Fitness Demonstration: "The Dancing Nurse", Shan'tel Davidson, Karisma Dance Fitness LLC

Event Volunteers Needed! Service hours and lunch are provided. To sign up and learn more, visit: Volunteer sign-up here


For in-person attendees: Check-in and Resource Fair start at 10 a.m. Lunch will be served.

For virtual attendees via Zoom: The live stream starts at 11 a.m.


There is no charge to attend, but registration is required since lunch will be served. This program is open to people with Parkinson's, their families, friends, and the community.

Sponsored by:

Upcoming Events

Educational Events

Mindfulness Mondays - Mental Wellbeing

Each month, Dr. Rush invites you to slow down, breathe, and reconnect with yourself and your Parkinson’s community through a guided mindfulness practice. Together, we’ll explore simple ways to ground the body, calm the mind, and cultivate compassion and clarity that you can carry into your week.

Virtual

My PD Story

Herbert Wennink headshot
People with PD

Herbert Wennink

I was 56 when I was diagnosed with Parkinson's disease (PD). Now, almost 10 years later, I look back on how the disease has affected my life but also how I continue to adapt. I never thought I’d be at the gym so much, or that I’d have to take early retirement, but I have learned that I am resilient and that even as the disease progresses, I can still have a great deal of joy in my life.

A few months before being diagnosed, I noticed symptoms of Parkinson’s, such as a small tremor in my hand and a loss of smell. At the urging of my wife, I saw my primary care doctor, who suspected Parkinson’s. I then saw a general neurologist who confirmed the diagnosis.

I sought a second opinion at Northwestern Medicine Parkinson’s Disease and Movement Disorders Center because it is a Parkinson’s Foundation Center of Excellence. Northwestern Medicine Neurologist Danny Bega, MD, confirmed my diagnosis and created a personalized treatment plan addressing not only medications, but also lifestyle changes and exercise to manage symptoms and enhance my quality of life.

A central element of my life is attending Rock Steady Boxing classes specifically designed for people with Parkinson’s. I also attend Parkinson’s-specific ping pong, golf and Second City Improv classes. Who knew Parkinson’s could be so funny? Many of these initiatives have received Parkinson’s Foundation community grants.

The Parkinson’s Foundation has been a key resource for providing me and my family with ongoing education. I found the Hospital Safety Guide to be helpful when I was diagnosed and continue to use it as a resource. Each year, I attend the Parkinson’s Disease Patient and Caregiver Symposium, co-hosted by the Parkinson’s Foundation and Northwestern Medicine, to stay updated on treatments and research. Through the Foundation’s events like Moving Day walks and Parkinson's Players activities, I have found support, camaraderie and a sense of belonging.

My journey with Parkinson’s disease has taught me many things. One is that Parkinson’s isn’t limited to older adults; it affects people of all ages and can happen to anyone.

Herbert Wennink on a hike

I’ve also learned to celebrate milestones. I’ve been living with Parkinson’s for nearly a decade, and every year that my symptoms are managed is a milestone. I appreciate that I have been able to live well enough to take several international trips with my wife and daughter since my diagnosis.

I am proud to have stuck with a vigorous exercise program over the years, and it’s paying off. I have definitely learned that exercise equals medicine, and the community of supportive coaches and friends is invaluable. I hope fellow people with PD will approach this disease with a positive attitude and a commitment to being active — and keep pushing to live the best life possible.

Learn more about the Northwestern Medicine Parkinson's Disease and Movement Disorders Center

Find the Parkinson’s exercise class that works for you! For virtual options, explore our Fitness Friday videos. For in-person classes, visit your local chapter’s webpage or call our Helpline at 1-800-4PD-INFO (1-800-473-4636).

My PD Story

Vanessa Russell-Palmer headshot
People with PD

Vanessa Russell-Palmer

My Parkinson’s disease (PD) story started with a severe orthopedic injury on July 26, 2015. I fell off a ladder in my garage and suffered a tibial plateau fracture of my left leg (I broke my left knee joint). After two weeks in the hospital and two surgeries, I was recuperating at my daughter’s house since I was non-weight bearing for over four months and could not live alone. In October, I noticed that whenever I was sitting still, I felt like my right hand was shaking, but when I looked at my hand, I couldn’t see any movement.

I mentioned this to my orthopedic surgeon and his initial thought was let’s keep an eye on it since I had suffered a lot of damage to my sciatic nerve because of my fall in July. 

By April of 2016 the internal tremor had turned into a resting tremor, and I scheduled an appointment to see a neurologist. I had my initial neurology appointment in June 2016. I scheduled the appointment over my lunch hour because quite frankly I thought the tremor was related to the nerve damage from my fall — a Parkinson’s diagnosis was the farthest thing from my mind.

During my visit the neurologist took me through a battery of tests. When the neurologist had completed all the screenings, she asked me if a family member came with me to the appointment — of course, by now I’m getting concerned. I said that I came alone as I scheduled this appointment over my lunch hour. The neurologist proceeded to tell me that I have young-onset Parkinson’s disease.

I was stunned and in shock. The neurologist explained that Parkinson’s is a clinical diagnosis and I had several of the movement symptoms (tremor, bradykinesia and rigid muscles). The neurologist also ordered some diagnostics tests including blood work, a brain MRI and a DaT scan.

A few months later, I sought a second opinion on my diagnosis and saw a movement disorders specialist (MDS) at Rush University Medical Center, a Parkinson’s Foundation Center of Excellence. It was confirmed — I indeed had Parkinson’s.

Initially, my symptoms were mild, so I wasn’t put on any medication, which was fine with me because I was still very much in denial. I went on with work like nothing was wrong, but that didn’t last very long.

By 2017, I was struggling to manage my work and personal activities. Working in international accounting, I traveled a lot for work. I would hide my tremor during presentations, but the non-movement symptoms overwhelmed me (fatigue, brain fog, insomnia). It wasn’t until my MDS put me on amantadine when I started to believe I had Parkinson’s.

In 2018, I retired from my position as an accounting manager at a pharmaceutical company. Retirement was the right decision for me because I could see how the stress of work coupled with all my other responsibilities was negatively affecting me and making my PD symptoms worse. I started taking Carbidopa-Levodopa.

Look for Vanessa in our new PSA aiming to help people find real answers to their Parkinson’s questions. 

Fast forward to now, 2024. I’m actively involved in the newly formed African American support group at Rush. It was through this support group that I learned about the Parkinson’s Foundation Learning Institute. I was immediately interested and thrilled to be chosen (along with my daughter who is my care partner).

In September 2023, I was in the first graduating class of all Black and African American research advocates.

As a Parkinson’s Foundation Research Advocate my focus is twofold:

1.  Participate in Parkinson’s research studies.

African Americans are severely under-represented in research studies, which can impact our ability to have effective therapies developed for us in the future. I wish I had more information early in my diagnosis because there were several studies that I could have participated in being newly diagnosed and not on medication for the first year of my diagnosis.

I was really excited to participate in PD GENEration because I knew I would get to talk to a genetic counselor, and I would see the results. I felt empowered while participating in PD GENEration because I was doing something about my Parkinson’s. I also felt relieved, because I didn't have any mutations. That made me feel better as far as my kids’ future. If something were to happen, and my children were to have Parkinson’s, there would hopefully be a whole different landscape for them treatment-wise versus what we have right now.

When it comes to participating in PD research and navigating life with this disease, I feel very strongly about sharing information with family.

PD GENEration just opened the door for me, and I felt more at ease about participating in research. PD GENEration was my first research study and I’ve participated in five studies since.

Vanessa Russell-Palmer and her daughter at an event

2.  Raise community awareness.

African Americans are less likely to be diagnosed with Parkinson’s due to lack of information and access to care (to name a few). We also need to understand the importance of participating in Parkinson’s research and to learn the early signs of Parkinson’s. I did not know that loss of smell and diminished taste is an early sign of PD, both of which I recall being an issue for me as early as 2012.

As a Parkinson’s Foundation research advocate, I want to break down the fear of talking about Parkinson’s and the fear of participating in research. I know we have a lot of issues based on prior history, but things are different now.

When I speak at community events — from health fairs in churches to our community center —  I tell people that when you participate in a study, you'll go through a confirmation process where you’ll get answers to all your questions. Research is something that can help you, not just right now, but down the line. That really does make it matter to me. I want us to be able to be represented in the PD GENEration database and have it be more diverse so everybody can get effective treatments for this disease.

In conclusion, I know that this disease can be overwhelming. Find something within the PD community that you are passionate about, there are so many areas that you can get involved in. I went from being in complete denial about my disease in 2016 to becoming a Parkinson’s Foundation research advocate in 2023. 

I now feel empowered to fight this disease every day and I have a community of support with my fellow research advocates, friends and family. Living with Parkinson’s is a long and sometimes uncertain journey, but even on my challenging days I know that I have an advocacy plan and that my efforts will make a difference in the long run — that is what keeps me going each day.

Explore ways to get involved in the Parkinson’s Foundation — from our research advocate program to joining a research study and exploring volunteer opportunities.

Educational Events

The PD Solo Network

Virtual ( Zoom )
1:00 pm to 2:30 pm EST
FREE
PD Solo event banner of woman staring out the window

Parkinson's Foundation Launches: The PD Solo Network - Living Alone While Living with PD

There are two sessions available: You are welcome to choose one or attend both.
– 1 p.m. to 2:30 p.m. ET
– 7:30 p.m. to 9 p.m. ET

What is the PD Solo Network: 

A virtual network for people living with Parkinson's disease (PD) who live alone, by choice or circumstance. The purpose of this group is to create a community of support for those living without a care partner. People living with PD are the experts about what challenges, changes and accommodations are needed on a daily basis. This network will provide a place to share ideas, concerns, brainstorm strategies, suggestions, resources & to build relationships.

The Parkinson's Foundation is providing the initial funding and support to kick start this network. It will most likely become a very strong network that will operate independently although the Parkinson's Foundation will always be an entity of support & information for the participants.

Upcoming Meeting Dates:

– February 13 and February 27, 2024
– March 12 and March 26, 2024
– April 9 and April 23, 2024

There is no charge to attend, but registration is required in order to receive the Zoom link.

This is a virtual program, taking place live, using the online Zoom platform. Instructions on joining the webinar are provided after registering.

Upcoming Events

Educational Events

Mindfulness Mondays - Mental Wellbeing

Each month, Dr. Rush invites you to slow down, breathe, and reconnect with yourself and your Parkinson’s community through a guided mindfulness practice. Together, we’ll explore simple ways to ground the body, calm the mind, and cultivate compassion and clarity that you can carry into your week.

Virtual
Educational Events

The PD Solo Network

Virtual ( Zoom )
1:00 pm to 2:30 pm EST
FREE
PD Solo event banner of woman staring out the window

Parkinson's Foundation Launches: The PD Solo Network - Living Alone While Living with PD

There are two sessions available: You are welcome to choose one or attend both.
– 1 p.m. to 2:30 p.m. ET
– 7:30 p.m. to 9 p.m. ET

What is the PD Solo Network: 

A virtual network for people living with Parkinson's disease (PD) who live alone, by choice or circumstance. The purpose of this group is to create a community of support for those living without a care partner. People living with PD are the experts about what challenges, changes and accommodations are needed on a daily basis. This network will provide a place to share ideas, concerns, brainstorm strategies, suggestions, resources & to build relationships.

The Parkinson's Foundation is providing the initial funding and support to kick start this network. It will most likely become a very strong network that will operate independently although the Parkinson's Foundation will always be an entity of support & information for the participants.

Upcoming Meeting Dates:

– April 9 and April 23, 2024

There is no charge to attend, but registration is required in order to receive the Zoom link.

This is a virtual program, taking place live, using the online Zoom platform. Instructions on joining the webinar are provided after registering.

Upcoming Events

Educational Events

Mindfulness Mondays - Mental Wellbeing

Each month, Dr. Rush invites you to slow down, breathe, and reconnect with yourself and your Parkinson’s community through a guided mindfulness practice. Together, we’ll explore simple ways to ground the body, calm the mind, and cultivate compassion and clarity that you can carry into your week.

Virtual
Educational Events

Social & Emotional Wellness

9:00 am to 1:00 pm EST
FREE
The referenced media source is missing and needs to be re-embedded.

Emotional and social health is an important part of living well with Parkinson’s disease. Many symptoms of Parkinson’s, such as anxiety, apathy and mood changes, can affect emotional and social wellness. Learn how various clinical and creative therapies can support not only symptom management but the overall well-being of the person living with PD.

Speakers joining us from the University of Vermont Medical Center:

  • James T. Boyd, MD
  • Suzanne M. Kennedy, MD
  • Lucas Kovacevich, MSW

 There is no charge to attend, but registration is required. This program is open to people with Parkinson's, their family, friends and the community.

Lunch will be provided.

COVID SAFETY: The health and safety of our participants, sponsors, volunteers and staff are our top priority. We continue to monitor CDC recommendations and will adhere to state and local COVID guidelines in place on the event day. Adjustments will be made if necessary.

Upcoming Events

Educational Events

Mindfulness Mondays - Mental Wellbeing

Each month, Dr. Rush invites you to slow down, breathe, and reconnect with yourself and your Parkinson’s community through a guided mindfulness practice. Together, we’ll explore simple ways to ground the body, calm the mind, and cultivate compassion and clarity that you can carry into your week.

Virtual
Educational Events

Navigating Advancing Needs

11:00 am to 2:00 pm EST
FREE
The referenced media source is missing and needs to be re-embedded.

EVENT RESCHEDULED for Wednesday, November 13, 2024

This program is open to anyone interested in learning more. You do not have to be a resident of The Villages to participate. All are welcome!

In-person check-in and exhibitor tables open at 10 a.m. ET. Program and presentations start at 11 a.m. ET. 

We will address some of the challenges of advancing PD and explore strategies to prepare for the future, including how to evolve your care plans and treatments throughout progression so you can live your best life with PD now.

There is no charge to attend, but registration is required. This program is open to people with Parkinson's, their families, friends, and the community.


Featured Speakers:

Ramon Rodriguez, MD, FAAN
Medical Director, Neurology One 

Bob Fuery, BS, R. Ph.

Karita Anderson, MSW
AdventHealth | Neuroscience

Jodi Lorenze MS, CCC/SLP
Director of Rehabilitation Services
UF Health Spanish Plaines Rehabilitation Hospital

Claudia Kerzner, CAP
Senior Proof

Amy Cearley
Tri-County Caregiver Resource Center

Rose Wichmann & Joan Gardner
National Co-Director's
Community Partners in Parkinson's Care
 

Sponsored by:

Kyowa Kirin

Upcoming Events

Educational Events

Mindfulness Mondays - Mental Wellbeing

Each month, Dr. Rush invites you to slow down, breathe, and reconnect with yourself and your Parkinson’s community through a guided mindfulness practice. Together, we’ll explore simple ways to ground the body, calm the mind, and cultivate compassion and clarity that you can carry into your week.

Virtual
Educational Events

New England Chapter Parkinson’s Symposium

Virtual ( Zoom )
10:00 am to 3:00 pm EST
FREE
New England Symposium Banner

Check-in starts at 10 a.m. ET for in-person participants

Join the Parkinson’s Foundation in person or online for the New England Chapter Parkinson’s Symposium. Hear about how ongoing research and genetics are providing clues to slowing progression, current treatments, and resources available to help you live your best life with Parkinson’s.

Speakers

Albert Hung, MD, PhD
Associate Neurologist, Neurology, Massachusetts General Hospital
Director, Parkinson's Disease Center of Excellence
Assistant Professor of Neurology, Harvard Medical School

David K. Simon, MD, PhD
Professor of Neurology, Harvard Medical School
Director, Parkinson’s Disease & Movement Disorders Center
Beth Israel Deaconess Medical Center, Parkinson’s Foundation Center of Excellence

Stephen L. Lee, MD, PhD
Co-Medical Director, Parkinson's Center, Dartmouth Hitchcock Medical Center, Parkinson’s Foundation Center of Excellence
Assistant Professor of Neurology, Geisel School of Medicine, Dartmouth

Joy Antonelle de Marcaida, MD
Medical Director, David & Rhoda Chase Family Movement Disorders Center, Hartford Hospital, Parkinson’s Foundation Comprehensive Care Center

Anna DePold Hohler, MD, FAAN
Chair of Neurology, St. Elizabeth’s Medical Center
Professor of Neurology, TUSM

Keith J. Ciccone, BS, LPN
Nurse Specialist
St. Elizabeth Medical Center


For in-person attendees: In-person check-in starts at  10 a.m. ET.  Lunch will also be provided during the event.

For virtual attendees, via Zoom: The live stream starts at 11 a.m. ET

COVID SAFETY: The health and safety of our participants, sponsors, volunteers and staff are our top priority. We continue to monitor CDC recommendations and will adhere to state and local COVID guidelines in place on the event day. Adjustments will be made if necessary.

Upcoming Events

Educational Events

Mindfulness Mondays - Mental Wellbeing

Each month, Dr. Rush invites you to slow down, breathe, and reconnect with yourself and your Parkinson’s community through a guided mindfulness practice. Together, we’ll explore simple ways to ground the body, calm the mind, and cultivate compassion and clarity that you can carry into your week.

Virtual
Podcasts

Episode 167: Exploring Carbidopa-Levodopa for Treating Parkinson’s Symptoms

Carbidopa-levodopa is considered the “gold standard treatment” for Parkinson’s disease. Levodopa works to replace levels of dopamine in the brain, thereby alleviating PD symptoms, while Carbidopa works to reduce adverse effects in the rest of the body. Although years have passed since the creation of this treatment, it is still commonly known to be an effective drug for reducing PD symptoms in a majority of people living with Parkinson’s.

In this episode, we hear from Dr. Emily Peron, PharmD and Dr. Leslie Cloud, MD from Virginia Commonwealth University*. They discuss how and why carbidopa-levodopa continues to be a standard treatment for PD, long-term use considerations, its different forms, and when to recognize the need for potential medication adjustments.

*Denotes a Parkinson's Foundation Center of Excellence

Released: March 5, 2024

Science News

New Cell Types Identified in Parkinson’s

Parkinson's Foundation Science News blogs

New research reveals the complex changes happening in different cell types in the brain that are affected by Parkinson's and identifies a unique population of neurons.

A hallmark of Parkinson's disease (PD) is the death of brain cells called dopaminergic neurons in a part of the brain called the substantia nigra. For people with Parkinson’s, these neurons stop producing dopamine, which helps control the body's movements and moods. However, it’s not clear if other types of cells are also affected.

A new study published in Science Advances identifies a new type of neuron associated with Parkinson’s. By looking at which genes were turned on and off in hundreds of thousands of different cells in the substantia nigra, the researchers developed an “atlas of gene expression.” This research may help us better understand Parkinson’s, and possibly help guide the development of new treatments.

This study was led by the Parkinson’s Foundation 2022 Research Centers Principal Investigator Zhenyu Yue, PhD, and co-Investigators Joel Blanchard, PhD, John Crary, MD, PhD and Bin Zhang, PhD, from Icahn School of Medicine at Mount Sinai.

About the Study & Results

Neurons

The researchers studied gene expression in 315,867 cells from the substantia nigra of people who did or did not have Parkinson's. Within the samples, the researchers identified various known cell types, including different types of neurons and other brain cells.

Interestingly, the scientists found a unique group of neurons that had an activated gene called RIT2, which past studies had shown is associated with Parkinson's risk. These cells lacked markers of other common cell types in the substantia nigra, indicating that they may be a newly recognized cell population.

However, in people who had advanced Parkinson’s, RIT2 expression was decreased compared to those without Parkinson’s, suggesting that reduced RIT2 expression may play a role in the development of Parkinson's. This may also indicate that the unique population of RIT2 neurons may be more vulnerable to the disease.

The team assembled their data on gene expression to create an atlas of different populations of single cells in the substantia nigra, which can be used to explain changes associated with Parkinson’s. They found distinct patterns of changes in gene expression in the cells marked by RIT2. Moreover, the team identified pathways of cell-to-cell communication that were altered in Parkinson’s.

Research Takeaways

The researchers are hopeful that this new data will be useful in future research. For example, while many dopaminergic neurons were lost due to advanced Parkinson’s by the time these samples were collected, many survived — their atlas may eventually help reveal what makes some neurons more resilient.

They also hope that this data will help:

  • Understand pathogenic mechanisms (how Parkinson’s works)
  • Identify new therapeutic targets
  • Help find clinical biomarkers for Parkinson’s. A PD biomarker would lead to faster and more accurate diagnosis and the ability to track PD progression. Right now, there is no single biomarker for Parkinson’s.

Highlights

  • A unique group of neurons in the substantia nigra is marked by an activated gene, called RIT2, which past studies have shown is associated with Parkinson's risk. These cells did not have markers of other known cell types, indicating that they had not been previously identified.
  • In people who had advanced Parkinson’s, RIT2 gene expression was reduced, which suggests it may play a role in the development of Parkinson's. It may also mean that the unique population of RIT2 neurons may be more vulnerable to the disease.
  • Data was converted into an “atlas of gene expression” that identifies a broad range of gene expression patterns within the cells of the substantia nigra.

What does this mean?

This research is a step towards better understanding the changes that occur in the substantia nigra during Parkinson’s. Knowing that there is a new population of brain neurons tied to Parkinson’s — in addition to the well-established dopaminergic neurons ­— will provide researchers with new targets to develop different PD medications. These neurons can also lead to the development of a new biomarker, which could be a breakthrough in PD diagnosis and progression tracking.

What do these findings mean to the people with PD right now?

While this study does not impact people with PD right now, the PD community can find hope in that researchers are still discovering more about this disease, and how it works. We can only solve a puzzle if we have all the pieces, and this new piece contributes to the overall battle to beat Parkinson’s.

People who are concerned that they may be experiencing Parkinson’s symptoms should talk to a healthcare provider.

Learn More

The Parkinson’s Foundation believes in empowering the Parkinson’s community through education. Learn more about PD and the topics in this article through our below resources, or by calling our free Helpline at 1-800-4PD-INFO (1-800-473-4636) for answers to your Parkinson’s questions.

Back to Top